Zain Rizvi

Yale University, Law School, Students

JD Candidate

127 Wall Street

New Haven, CT 06511

United States

  • Yale University, Law School, Students

SCHOLARLY PAPERS

7

DOWNLOADS

1,799

TOTAL CITATIONS

8

Scholarly Papers (7)

Actions:
Email selected abstracts
1.

Curbing Unfair Drug Prices: A Primer for States

Global Health Justice Partnership Policy Paper, August 2017
Number of pages: 24 Posted: 27 Nov 2017
Aaron Berman, Theodore Lee, Adam Pan, Zain Rizvi and Arielle Thomas
Yale School of Public Health, Yale University, Law School, Students, Yale University, Law School, Students, Yale University, Law School, Students and Yale School of Public Health
Downloads 873 (59,168)

Abstract:

Loading...

Prescription, Drug Prices, Health, States, Federalism, Trade Secret, Patent Law, Transparency

2.

A Prescription for Excessive Drug Pricing: Leveraging Government Patent Use for Health

18 Yale J. L. & Tech. 275 (2016), Yale Law School, Public Law Research Paper No. 577, Yale Law & Economics Research Paper No. 560
Number of pages: 80 Posted: 03 Sep 2016 Last Revised: 21 Sep 2016
Hannah Brennan, Amy Kapczynski, Christine Monahan and Zain Rizvi
Hagens Berman Sobol Shapiro, Yale University - Law School, Independent and Yale University, Law School, Students
Downloads 680 (82,209)
Citation 6

Abstract:

Loading...

pharmaceuticals, medicines, patents, healthcare, hepatitis C, eminent domain

3.

An International Legal Framework to Address Antimicrobial Resistance

Downloads 102 (326,577)

An International Legal Framework to Address Antimicrobial Resistance

Bulletin of the World Health Organization, 2015, 93:66
Number of pages: 1 Posted: 05 Feb 2016
Steven Hoffman, Kevin Outterson, John-Arne Røttingen, Otto Cars, Charles Clift, Zain Rizvi, Fiona Rotberg, Göran Tomson and Anna Zorzet
York University, Boston University School of Law, Norwegian Knowledge Center for the Health Services, ReAct - Action on Antibiotic Resistance, Centre on Global Health Security - Chatham House, Yale University, Law School, Students, Dag Hammarskjöld Foundation, Karolinska Institutet and ReAct - Action on Antibiotic Resistance
Downloads 102 (564,151)

Abstract:

Loading...

antimicrobial, resistance, global, health, threat, access, conservation, innovation, coordnation, mechanism

4.

Should the U.S. Government Actively Assert its Own Patents?

NYU Journal of Intellectual Property & Entertainment Law, 11
Number of pages: 22 Posted: 18 Nov 2021
Christopher Morten, Amy Kapczynski and Zain Rizvi
Columbia Law School, Yale University - Law School and Yale University, Law School, Students
Downloads 67 (717,488)

Abstract:

Loading...

Symposium, Access, Medicine, COVID, Coronavirus, NYU, Prescription, Drugs, Government, Healthcare, Insurance, Research, Pharmaceutical, Pharma, NIH, Pandemic, Vaccine, Patent, Intellectual Property, IP, Licensing, Public Health, Biomedical, Bioethics, Policy

5.

WHO's Undermining Tobacco Control

The Lancet, August 2012, Vol. 380
Number of pages: 2 Posted: 05 Feb 2016
Steven Hoffman and Zain Rizvi
York University and Yale University, Law School, Students
Downloads 48 (844,675)
Citation 2

Abstract:

Loading...

World, health, organization, WHO, Tobacco, framework, convention, control, FCTC, natonal, system, database

6.

Effective Global Action on Antibiotic Resistance Requires Careful Consideration of Convening Forums

Journal of Law, Medicine and Ethics, Vol. 43, No. 2, 2015, Ottawa Faculty of Law Working Paper No. 2016-09
Number of pages: 7 Posted: 01 Feb 2016 Last Revised: 11 May 2016
Zain Rizvi and Steven Hoffman
Yale University, Law School, Students and York University
Downloads 29 (1,025,460)

Abstract:

Loading...

policy, policymakers, global, collective, action, antibiotic, resistance, ABR, international, law, forum, political, multi-sectoral, advantages, drawbacks

7.

International Cooperation to Improve Access to and Sustain Effectiveness of Antimicrobials

The Lancet, Volume 387, No. 10015, pp. 296-307, 2016, Boston Univ. School of Law, Public Law Research Paper No. 16-16, Ottawa Faculty of Law Working Paper No. 2016-22
Posted: 04 May 2016 Last Revised: 19 Jun 2021
Christine Årdal, Kevin Outterson, Steven Hoffman, Abdul Ghafur, Mike Sharland, Nisha Ranganathan, Richard Smith, Anna Zorzet, Jennifer Cohn, Didier Pittet, Nils Daulaire, Chantal Morel, Zain Rizvi, Manica Balasegaram, Osman Dar, David L. Heymann, Alison Holmes, Luke Moore, Ramanan Laxminarayan, Marc Mendelson and John-Arne Røttingen
University of Oslo, Boston University School of Law, York University, Apollo Hospital, St. George’s University of London - Paediatric Infectious Diseases Research Group, Royal Free Hospital, University of Exeter - Faculty of Health and Life Sciences, ReAct - Action on Antibiotic Resistance, University of Pennsylvania - Department of Medicine, Division of Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine - Infection Control Programme, Georgetown University Law Center, McGill University, Yale University, Law School, Students, Global Antibiotic Research and Development Partnership (GARDP), Chatham House - Centre on Global Health Security, World Health Organization - Communicable Diseases, McGill University, Imperial College London, One Health Trust, University of Cape Town (UCT) - Division of Infectious Diseases & HIV Medicine and Norwegian Knowledge Center for the Health Services

Abstract:

Loading...

antibiotic resistance, patents, intellectual property, health law, pandemics